Research Compounds

EPO-derived 11-amino acid peptide studied for tissue-protective receptor (TPR) signaling, neuropathy modulation, and anti-inflammatory effects in preclinical models.

Synthetic tetrapeptide derived from the pineal gland studied for telomerase activation, circadian rhythm regulation, and antioxidant effects in aging research models.

Master antioxidant tripeptide studied for oxidative stress reduction, detoxification pathway support, and immune cell function modulation in cell biology research.

Comprehensive four-compound research blend combining BPC-157, GHK-Cu, TB-500, and KPV for multi-pathway tissue repair and anti-inflammatory research.

C-terminal alpha-MSH tripeptide studied for anti-inflammatory cytokine modulation and mucosal healing properties in cell culture research.

Human cathelicidin antimicrobial peptide studied for immune modulation, angiogenesis promotion, and wound healing facilitation in preclinical models.

Synthetic analogue of tuftsin studied for anxiolytic, nootropic, and immunomodulatory effects on GABA and serotonin pathways in preclinical models.

Thymic peptide researched for its role in actin regulation, cell migration, angiogenesis, and wound healing signaling in preclinical models.

Thymus-derived peptide studied for immune restoration, T-cell regulation, and neuroendocrine modulation in aging and immunodeficiency research models.

Dipeptide (Lys-Glu) studied for thymic peptide-like activity, immune restoration, and vascular endothelium function modulation in aging research models.

28-amino acid neuropeptide studied for vasodilatory, anti-inflammatory, bronchodilatory, and immunomodulatory signaling in a wide range of research models.